Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-12 Sale |
2025-03-14 4:30 pm |
Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, CHIEF MEDICAL OFFICER |
3,596 | $1.14 | $4,099 | 227,813 (Direct) |
View |
2025-03-12 Sale |
2025-03-14 4:30 pm |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER |
5,611 | $1.14 | $6,397 | 80,297 (Direct) |
View |
2025-03-12 Sale |
2025-03-14 4:30 pm |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, CHIEF FINANCIAL OFFICER |
6,884 | $1.14 | $7,848 | 54,786 (Direct) |
View |
2025-03-12 Sale |
2025-03-14 4:30 pm |
Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell PRESIDENT AND CEO |
21,179 | $1.14 | $24,144 | 231,952 (Indirect Direct) |
View |
2024-03-28 Sale |
2024-04-01 9:31 pm |
Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell PRESIDENT AND CEO |
5,141 | $4.6248 | $23,776 | 210,236 (Indirect Direct) |
View |
2024-03-28 Sale |
2024-04-01 9:30 pm |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, CHIEF FINANCIAL OFFICER |
1,614 | $4.6151 | $7,449 | 44,775 (Direct) |
View |
2024-03-28 Sale |
2024-04-01 9:28 pm |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER |
860 | $4.6495 | $3,999 | 71,908 (Direct) |
View |
2024-03-28 Sale |
2024-04-01 9:27 pm |
Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, CHIEF MEDICAL OFFICER |
800 | $4.6475 | $3,718 | 231,409 (Direct) |
View |
2024-03-25 Sale |
2024-03-27 6:59 pm |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, CHIEF FINANCIAL OFFICER |
2,475 | $4.67 | $11,558 | 42,212 (Direct) |
View |
2024-03-25 Sale |
2024-03-27 6:57 pm |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER |
1,350 | $4.67 | $6,305 | 72,768 (Direct) |
View |
2024-03-25 Sale |
2024-03-27 6:56 pm |
Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, CHIEF MEDICAL OFFICER |
1,500 | $4.6667 | $7,000 | 232,209 (Direct) |
View |
2024-03-25 Sale |
2024-03-27 6:54 pm |
Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell PRESIDENT AND CEO |
7,950 | $4.6867 | $37,259 | 208,543 (Indirect Direct) |
View |
2023-11-15 Purchase |
2023-11-17 4:54 pm |
Repare Therapeutics Inc. | RPTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
1,227,301 | $5.0924 | $6,249,889 | 548,938 (Direct) |
View |
2023-11-02 Purchase |
2023-11-03 5:37 pm |
Repare Therapeutics Inc. | RPTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
783,709 | $3.6 | $2,821,352 | 485,083 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-02 Option Award |
2025-04-04 4:15 pm |
N/A 2035-04-01 |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, CHIEF FINANCIAL OFFICER |
500,000 | $0 | 500,000 (Direct) |
View |
2025-03-04 Option Award |
2025-03-06 5:00 pm |
N/A 2035-03-03 |
Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell PRESIDENT AND CEO |
277,000 | $0 | 490,131 (Direct) |
View |
2025-03-04 Option Award |
2025-03-06 5:00 pm |
N/A 2035-03-03 |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER |
174,000 | $0 | 245,908 (Direct) |
View |
2025-03-04 Option Award |
2025-03-06 5:00 pm |
N/A 2035-03-03 |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, CHIEF FINANCIAL OFFICER |
299,000 | $0 | 346,670 (Direct) |
View |
2024-06-17 Option Award |
2024-06-20 4:36 pm |
N/A 2034-06-16 |
Repare Therapeutics Inc. | RPTX | SCHAFER CAROL Director |
27,200 | $0 | 27,200 (Direct) |
View |
2024-06-17 Option Award |
2024-06-20 4:35 pm |
N/A 2034-06-16 |
Repare Therapeutics Inc. | RPTX | RHOADS ANN D Director |
27,200 | $0 | 27,200 (Direct) |
View |
2024-06-17 Option Award |
2024-06-20 4:35 pm |
N/A 2034-06-16 |
Repare Therapeutics Inc. | RPTX | Morrison Briggs Director |
27,200 | $0 | 27,200 (Direct) |
View |
2024-06-17 Option Award |
2024-06-20 4:35 pm |
N/A 2034-06-16 |
Repare Therapeutics Inc. | RPTX | Molineaux Susan Director |
27,200 | $0 | 27,200 (Direct) |
View |
2024-06-17 Option Award |
2024-06-20 4:35 pm |
N/A 2034-06-16 |
Repare Therapeutics Inc. | RPTX | Kulkarni Samarth Director |
27,200 | $0 | 27,200 (Direct) |
View |
2024-06-17 Option Award |
2024-06-20 4:35 pm |
N/A 2034-06-16 |
Repare Therapeutics Inc. | RPTX | Bonita David P Director |
27,200 | $0 | 27,200 (Direct) |
View |
2024-06-17 Option Award |
2024-06-20 4:35 pm |
N/A 2034-06-16 |
Repare Therapeutics Inc. | RPTX | Civik Thomas Director |
27,200 | $0 | 27,200 (Direct) |
View |
2024-06-17 Option Award |
2024-06-20 4:35 pm |
N/A 2034-06-16 |
Repare Therapeutics Inc. | RPTX | Stein Steven H Director |
54,000 | $0 | 54,000 (Direct) |
View |
2024-03-01 Option Award |
2024-03-05 4:15 pm |
N/A 2034-02-28 |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, CHIEF FINANCIAL OFFICER |
99,000 | $0 | 129,687 (Direct) |
View |
2024-03-01 Option Award |
2024-03-04 9:06 pm |
N/A 2034-02-28 |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER |
99,000 | $0 | 159,118 (Direct) |
View |
2024-03-01 Option Award |
2024-03-04 9:04 pm |
N/A 2034-02-28 |
Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell PRESIDENT AND CEO |
277,000 | $0 | 456,143 (Direct) |
View |
2024-03-01 Option Award |
2024-03-04 9:02 pm |
N/A 2034-02-28 |
Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, CHIEF MEDICAL OFFICER |
99,000 | $0 | 318,709 (Direct) |
View |
2023-12-11 Exercise |
2023-12-12 4:19 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer |
20,190 | $2.062 | 331,629 (Direct) |
View |
2023-12-11 Exercise |
2023-12-12 4:19 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer |
23,556 | $2.425 | 331,629 (Direct) |
View |
2023-12-11 Exercise |
2023-12-12 4:19 pm |
N/A 2029-05-01 |
Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer |
43,746 | $0 | 331,629 (Direct) |
View |
2023-06-08 Option Award |
2023-06-12 4:32 pm |
N/A 2033-06-07 |
Repare Therapeutics Inc. | RPTX | SCHAFER CAROL Director |
27,200 | $0 | 27,200 (Direct) |
View |
2023-06-08 Option Award |
2023-06-12 4:30 pm |
N/A 2033-06-07 |
Repare Therapeutics Inc. | RPTX | RHOADS ANN D Director |
27,200 | $0 | 27,200 (Direct) |
View |
2023-06-08 Option Award |
2023-06-12 4:27 pm |
N/A 2033-06-07 |
Repare Therapeutics Inc. | RPTX | Morrison Briggs Director |
27,200 | $0 | 27,200 (Direct) |
View |
2023-06-08 Option Award |
2023-06-12 4:26 pm |
N/A 2033-06-07 |
Repare Therapeutics Inc. | RPTX | Molineaux Susan Director |
76,200 | $0 | 76,200 (Direct) |
View |
2023-06-08 Option Award |
2023-06-12 4:25 pm |
N/A 2033-06-07 |
Repare Therapeutics Inc. | RPTX | Kulkarni Samarth Director |
27,200 | $0 | 27,200 (Direct) |
View |
2023-06-08 Option Award |
2023-06-12 4:24 pm |
N/A 2033-06-07 |
Repare Therapeutics Inc. | RPTX | Foley Todd Director |
27,200 | $0 | 27,200 (Direct) |
View |
2023-06-08 Option Award |
2023-06-12 4:22 pm |
N/A 2033-06-07 |
Repare Therapeutics Inc. | RPTX | Civik Thomas Director |
27,200 | $0 | 27,200 (Direct) |
View |
2023-06-08 Option Award |
2023-06-12 4:20 pm |
N/A 2033-06-07 |
Repare Therapeutics Inc. | RPTX | Bonita David P Director |
27,200 | $0 | 27,200 (Direct) |
View |